Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases | Journal of Medicinal Chemistry
JAK inhibitors for Atopic Dermatitis – STAT!
Frontiers | Emerging Topical and Systemic JAK Inhibitors in Dermatology
IJMS | Free Full-Text | Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases | Journal of Medicinal Chemistry
Ruxolitinib | CAS 941678-49-5 | InvivoGen
Rheumatoid arthritis | JAK inhibitors: The next generation of drugs for treating rheumatoid arthritis? | rheumatology.medicinematters.com
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application | Biomarker Research | Full Text
Pathways: JAK-STAT Signaling | www.antibodies-online.com
Hypoglycaemia following JAK inhibitor treatment in patients with diabetes | Annals of the Rheumatic Diseases
Targeting the JAK/STAT pathway in solid tumors
Frontiers | JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
Current and future status of JAK inhibitors - The Lancet
The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology
Viruses | Free Full-Text | JAK-STAT Pathway: A Novel Target to Tackle Viral Infections
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19: Trends in Pharmacological Sciences
JAKs and STATs in Immunity, Immunodeficiency, and Cancer | NEJM
The molecular details of cytokine signaling via the JAK/STAT pathway - Morris - 2018 - Protein Science - Wiley Online Library
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19: Trends in Pharmacological Sciences
The Role of Natural Products as Inhibitors of JAK/STAT Signaling Pathways in Glioblastoma Treatment
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
Frontiers | Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies
